Bottom line
Is GMOV a good fund? The bottom line
GMOV is a managed large value ETF from Gmo.
Its expense ratio is 0.5% — about $50 a year on every $10,000 invested, cheaper than 81% of large value funds we track.
It returned +14.8% over one year (as of Dec 31, 2025, per its prospectus).
With $90.9 million in net assets and 165 holdings, its largest position is Meta Platforms Inc (5.2%) and the top 10 make up 28.4% of the portfolio.
What stands out
- Low cost: cheaper than 81% of large value peers
Updated Nov 19, 2026
What GMOV invests in
Total return.
"The Fund is an actively managed ETF that seeks to achieve its investment objective by investing the Funds assets primarily in securities traded in U.S. equity markets. GMO selects the securities the Fund buys and sells based on its evaluation of companies published financial information, securities prices, equity and other markets, the overall global economy, and governmental policies. The Fund seeks to capitalize opportunistically on what GMO believes to be market dislocations within the U.S. equity markets. In selecting securities for the Fund, GMO uses a combination of proprietary quantitative investment methods to identify U.S. equities GMO believes have positive return potential relative to other U.S. equities. A key component of the process is GMOs proprietary methodology for assessing values of company tangible and intangible assets and generating equity return forecasts, which…
From the fund's prospectus (filed Jun 30, 2026).
GMOV performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| GMOV | +14.8% | — | — |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2025
What GMOV costs
On a $10,000 investment, GMOV's 0.5% expense ratio costs about $50 a year. The prospectus estimates $628 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
GMOV top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Meta Platforms Inc | 5.18% |
| 2 | Alphabet Inc | 3.89% |
| 3 | QUALCOMM Inc | 3.36% |
| 4 | Merck & Co Inc | 2.73% |
| 5 | Exxon Mobil Corp | 2.58% |
| 6 | Verizon Communications Inc | 2.37% |
| 7 | Bank of America Corp | 2.19% |
| 8 | Pfizer Inc | 2.10% |
| 9 | UnitedHealth Group Inc | 2.02% |
| 10 | Johnson & Johnson | 1.98% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 28.4% of the fund. See all top 25 holdings and asset mix →